Selank

Compound Overview

Selank is a synthetic heptapeptide built from the tuftsin sequence (Thr-Lys-Pro-Arg) with a Pro-Gly-Pro extension. Controlled laboratory research examines its modulation of BDNF, serotonin (5-HT), dopamine, and enkephalin signaling, along with anxiolytic, nootropic, and immunomodulatory properties.

Research Background & Published Literature

Selank was developed at the Institute of Molecular Genetics, Russian Academy of Sciences, and has been published in Bulletin of Experimental Biology and Medicine. Preclinical literature has studied cognitive enhancement, anxiolytic effects, and immune modulation in controlled experimental models.

Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:

• Czabak-Garbacz et al. (2006) — Pharmacol Rep
• Filatova et al. (2017) — Front Pharmacol
• Kolik et al. (2019) — Bull Exp Biol Med

Storage, Handling & Stability Guidelines

Use the applicable lot/source record for storage of unopened material. Any diluent selection, preparation, temperature, aliquoting, or post-reconstitution hold conditions must be established by a qualified laboratory under a validated SOP; this page does not establish a stability window.

• Keep ambient-temperature handling time as short as practical to support compound integrity.
• Reseal vials promptly after each withdrawal to limit moisture exposure.
• Use appropriate personal protective equipment and follow institutional chemical safety protocols at all times.
• For traceability, label all aliquots with compound name, concentration, reconstitution date, and operator initials.

Quality Assurance & Lab Verification

A finalized public Certificate of Analysis is available for this catalog item. Review the public COA for the applicable lot. Lot-specific identifiers, assay values, and methods are maintained in that record and are not repeated in this product dossier.